On December 25, 1992, The Lancet published a paper that permanently changed the prospects for men with severe infertility. A team at a Brussels clinic, led by Gianpiero Palermo and André Van Steirteghem, described a technique in which a single sperm cell was injected directly into the cytoplasm of an egg using an extraordinarily fine glass micropipette. The method became known as ICSI — intracytoplasmic sperm injection. Before that point, even the most advanced IVF labs needed hundreds of thousands of actively motile sperm to have a shot at fertilization. After it, a single one would do. Any single one — even immotile, even one retrieved surgically straight from testicular tissue rather than from an ejaculate.
That discovery, quite literally, created a new medical specialty. Men with no sperm at all in their ejaculate — a condition called azoospermia, which affects nearly 1% of all men — suddenly had a genuine path to biological fatherhood. All that was needed was a safe way to retrieve sperm directly from the reproductive organs. Four surgical techniques quickly emerged and developed around exactly that goal, and they're the ones people ask about most often: PESA, MESA, TESE, and Micro-TESE.
Before choosing a method, a doctor first has to figure out which type of azoospermia they're dealing with. Obstructive azoospermia means sperm production is entirely normal, but sperm can't reach the ejaculate because of a physical blockage — congenital absence of the vas deferens, the after-effects of a vasectomy, or an infection, for instance. In that case, sperm are usually easy to find in the epididymis, the tube where they physically accumulate and mature after leaving the testis. Non-obstructive azoospermia is a far more difficult situation: the problem isn't a blockage at all, but sperm production itself, disrupted or severely reduced inside the testicular tissue. Here, the epididymis usually contains no sperm whatsoever, so the search has to happen directly inside the testicular tissue — and not evenly throughout it, but in isolated pockets where some degree of sperm production has managed to survive.
| Method | Where sperm comes from | How it's done | When it's used |
|---|---|---|---|
| PESA | Epididymis | A needle through the skin, no incision | Obstructive azoospermia |
| MESA | Epididymis | Open surgery under an operating microscope | Obstructive azoospermia, especially with absent vas deferens |
| TESE | Testicular tissue itself | Biopsy of one or more small samples | Non-obstructive azoospermia, or obstructive cases where PESA/MESA failed |
| Micro-TESE | Testicular tissue, targeted | Testis opened and examined under an operating microscope, selecting dilated tubules | Non-obstructive azoospermia — the gold standard |
PESA is the gentlest of the four: a doctor inserts a thin needle through the scrotal skin straight into the epididymis and aspirates — draws out — fluid containing sperm. No incision is needed, the procedure takes only minutes, and it's usually done under local anesthesia. The main downside is that it's done blind, without any visual guidance, so if the first attempt doesn't turn up sperm, the accuracy of further attempts drops.
MESA, first described by Sherman Silber in 1988 for men born without a vas deferens, requires open surgical access and an operating microscope. The surgeon visually locates dilated tubules within the epididymis and opens them with precision, yielding considerably more material than PESA — usually enough for several ICSI cycles plus freezing a reserve supply for the future.
TESE moves past the epididymis entirely and biopsies the testicular tissue itself, where sperm are actually produced. It's used both for non-obstructive azoospermia and for obstructive cases where PESA and MESA came up empty. Standard TESE involves taking one or several small tissue samples without any visual guidance over which parts of the testis get sampled.
Micro-TESE, introduced by urologist Peter Schlegel in 1999, answered the biggest problem with standard TESE in non-obstructive azoospermia: finding pockets of surviving sperm production sometimes required taking so many tissue samples that the testis itself got damaged, occasionally reducing testosterone output. With Micro-TESE, the testis is opened and examined under an operating microscope at high magnification, visually selecting the wider, more dilated seminiferous tubules — statistically, those are the ones most likely to contain mature sperm. That allows surgeons to take less tissue while improving the odds of success.
In obstructive azoospermia, PESA or MESA find sperm almost every time — success rates approach 100%, since the problem is purely mechanical and sperm production itself is undisturbed. With non-obstructive azoospermia, the picture is much more complicated: according to systematic reviews, standard TESE finds sperm in roughly 30 to 50% of cases, while Micro-TESE pushes that figure up to 40 to 60%, sometimes higher still in the hands of highly experienced surgical teams. That's exactly why Micro-TESE is now considered the gold standard for the non-obstructive form, even though it demands more sophisticated equipment and surgical skill than the other three methods.
Embryologists assess retrieved sperm under a microscope right away, and either use them for ICSI in the same cycle — timed to coincide with the partner's egg retrieval — or cryopreserve them, freezing them in liquid nitrogen for one or several future attempts. Cryopreservation matters especially in non-obstructive azoospermia: if the surgical search succeeds, it makes sense to freeze every bit of usable material, sparing the man a repeat operation for the next IVF attempt.
Even in skilled hands, Micro-TESE doesn't guarantee a result in non-obstructive azoospermia: sperm genuinely are found in 40 to 60% of cases, which also means that in the remaining cases, nothing turns up despite every effort. For couples in that latter group, the next step is often a conversation about donor sperm — and it genuinely helps to approach that decision with some preparation already done, rather than in the middle of the emotional aftermath of a failed surgery.
For MAPASGEN users, that means it's worth exploring donor banks and donation rules across different countries in parallel with the surgical retrieval process — even while still hoping for a successful Micro-TESE. That way, if the procedure doesn't work out, the decision gets made calmly and with full information, not in a rush. It's also worth noting that non-obstructive azoospermia sometimes has a genetic root cause — Y-chromosome microdeletions or Klinefelter syndrome, for example — and in those cases it's worth discussing genetic counseling alongside the surgical step, including for assessing risks relevant to future donation or natural conception among relatives.
Unlike egg donation or PGT-A, surgical sperm retrieval for male infertility runs into essentially no legal restrictions anywhere — it's a recognized medical procedure nearly everywhere. The real differences between countries mostly come down to equipment availability, the concentration of experienced andrological surgeons, and how much insurance covers.
| Country | Access to surgical sperm retrieval | Notable detail |
|---|---|---|
| United Kingdom | Widely available | Micro-TESE is concentrated at large specialist andrology centres |
| Spain | Widely available | One of Europe's largest male-infertility treatment markets |
| Germany | Available | A well-developed network of urology clinics attached to IVF centres |
| France | Available | Procedures are usually partly covered by health insurance |
| Denmark | Available | High level of specialisation in andrological surgery |
| Portugal | Available | Used alongside IVF/ICSI programmes |
| Czech Republic | Available | Noticeably lower cost than in Western Europe |
| Israel | Widely available | One of the world's centres of expertise for Micro-TESE microsurgery |
| Brazil | Available in major cities | A growing market for reproductive andrology |
| Greece | Available | Often combined with sperm donor programmes if retrieval fails |
| Cyprus | Available | Growing as part of the medical tourism sector |
| Ukraine | Available | Affordable pricing combined with experienced specialists |
Israel and the UK stand out for their concentration of major centres with specific Micro-TESE experience — a technique that demands particular surgical skill and expensive equipment. In Spain and Germany, these procedures are well integrated into IVF clinic networks, making it easier to coordinate the surgical step with the partner's cycle. The Czech Republic and Ukraine offer noticeably lower costs at a comparable level of specialist training, making them popular destinations for couples who want to balance quality of care against a tighter budget.
The journey from that first injection of a single sperm cell into an egg in 1992 to today's microsurgical operations under high magnification is, at its core, the story of one simple but transformative observation: sometimes, starting a new life doesn't require a million sperm — just exactly one, found in a place nobody had thought to look before.